NasdaqCM - Delayed Quote • USD
Rockwell Medical, Inc. (RMTI)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:58 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.04 | -0.03 | -0.1 | 0.06 |
| Low Estimate | -0.05 | -0.03 | -0.11 | 0.06 |
| High Estimate | -0.03 | -0.03 | -0.09 | 0.06 |
| Year Ago EPS | -0.1 | -0.18 | -0.36 | -0.1 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 21.7M | 21.8M | 88.97M | 101M |
| Low Estimate | 21.18M | 21.27M | 88.08M | 97.96M |
| High Estimate | 22.22M | 22.33M | 89.87M | 104.04M |
| Year Ago Sales | 19.12M | 18.08M | 83.61M | 88.97M |
| Sales Growth (year/est) | 13.50% | 20.60% | 6.40% | 13.50% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.16 | -0.12 | -0.1 | -0.07 |
| EPS Actual | -0.1 | -0.18 | -0.07 | -0.05 |
| Difference | 0.06 | -0.06 | 0.03 | 0.02 |
| Surprise % | 37.50% | -50.00% | 30.00% | 28.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.04 | -0.03 | -0.1 | 0.06 |
| 7 Days Ago | -0.04 | -0.03 | -0.1 | 0.06 |
| 30 Days Ago | -0.06 | -0.04 | -0.12 | 0.05 |
| 60 Days Ago | -0.06 | -0.04 | -0.12 | 0.05 |
| 90 Days Ago | -0.06 | -0.04 | -0.12 | 0.05 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | RMTI | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 60.00% | -- | -- | 1.60% |
| Next Qtr. | 83.30% | -- | -- | 10.50% |
| Current Year | 72.20% | -- | -- | 5.20% |
| Next Year | 160.00% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 38.00% | -- | -- | 11.22% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/25/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/15/2023 |
| Initiated | Maxim Group: Buy | 10/5/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/4/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/28/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/15/2023 |
Related Tickers
ETON Eton Pharmaceuticals, Inc.
3.1900
+4.25%
CPIX Cumberland Pharmaceuticals Inc.
1.6000
-3.03%
AGRX Agile Therapeutics, Inc.
0.3800
+2.70%
ORGO Organogenesis Holdings Inc.
2.9000
+1.40%
DCPH Deciphera Pharmaceuticals, Inc.
14.67
+3.09%
AYTU Aytu BioPharma, Inc.
2.7900
0.00%
CYTH Cyclo Therapeutics, Inc.
1.1600
-3.33%
GHSI Guardion Health Sciences, Inc.
7.99
-0.75%
ASRT Assertio Holdings, Inc.
0.7730
+2.52%
HROW Harrow, Inc.
10.45
-3.69%